Literature DB >> 1699267

The use of enzyme immunoassay (EIA) and radiobinding assay to investigate the cross-reactivity of Klebsiella antigens and HLA B27 in ankylosing spondylitis patients and healthy controls.

M Baines1, A Ebringer, H Avakian, D Samuel, D C James.   

Abstract

The binding of rabbit anti-Klebsiella antibodies to tissue-typed lymphocytes obtained from 30 ankylosing spondylitis (AS) patients and 54 healthy subjects has been measured by an enzyme immunoassay method. HLA B27 positive lymphocytes obtained from either AS patients (t = 3.60; p less than 0.001) or healthy subjects (t = 3.77; p less than 0.001) were found to bind Klebsiella antibodies to a significantly greater extent than non-B27 lymphocytes obtained from healthy controls. Absorption studies demonstrated that HLA B27 positive lymphocytes absorbed out significantly more anti-Klebsiella antibodies than HLA B27-negative lymphocytes (t = 6.76; p less than 0.005). These results are compatible with cross-reactivity or molecular mimicry between HLA B27 and epitopes on some Gram-negative bacteria such as Klebsiella.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1699267     DOI: 10.3109/03009749009096789

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  8 in total

Review 1.  Infection and autoimmune disease.

Authors:  Asli Gamze Sener; Ilhan Afsar
Journal:  Rheumatol Int       Date:  2012-07-19       Impact factor: 2.631

Review 2.  HLA-B27 associated spondyloarthropathy, an autoimmune disease based on crossreactivity between bacteria and HLA-B27?

Authors:  J H Ringrose
Journal:  Ann Rheum Dis       Date:  1999-10       Impact factor: 19.103

Review 3.  Raised incidence of ankylosing spondylitis among Inuit populations could be due to high HLA-B27 association and starch consumption.

Authors:  Taha Rashid; Clyde Wilson; Alan Ebringer
Journal:  Rheumatol Int       Date:  2014-11-11       Impact factor: 2.631

4.  The potential of selected South African plants with anti-Klebsiella activity for the treatment and prevention of ankylosing spondylitis.

Authors:  I E Cock; S F van Vuuren
Journal:  Inflammopharmacology       Date:  2014-11-21       Impact factor: 4.473

5.  Inhibition of Klebsiella pneumoniae growth by selected Australian plants: natural approaches for the prevention and management of ankylosing spondylitis.

Authors:  V Winnett; J Sirdaarta; A White; F M Clarke; I E Cock
Journal:  Inflammopharmacology       Date:  2017-02-27       Impact factor: 4.473

Review 6.  Molecular mimicry: the geographical distribution of immune responses to Klebsiella in ankylosing spondylitis and its relevance to therapy.

Authors:  A Ebringer; K Ahmadi; M Fielder; T Rashid; H Tiwana; C Wilson; A Collado; Y Tani
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

Review 7.  Ankylosing spondylitis is linked to Klebsiella--the evidence.

Authors:  Taha Rashid; Alan Ebringer
Journal:  Clin Rheumatol       Date:  2006-12-21       Impact factor: 3.650

8.  Autoimmunity in Rheumatic Diseases Is Induced by Microbial Infections via Crossreactivity or Molecular Mimicry.

Authors:  Taha Rashid; Alan Ebringer
Journal:  Autoimmune Dis       Date:  2012-02-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.